PUBLICATIONS · 31078463
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2019 Jun
- First author
- Wilky BA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2019 Jun;20(6):750-752. doi: 10.1016/S1470-2045(19)30286-4.
- note
- Source null
- related pmid
- 31078464
- relationship
- Comment in
Authors and identifiers
- name
- Wilky BA
- type
- Author
- name
- Trucco MM
- type
- Author
- name
- Subhawong TK
- type
- Author
- name
- Florou V
- type
- Author
- name
- Park W
- type
- Author
- name
- Kwon D
- type
- Author
- name
- Wieder ED
- type
- Author
- name
- Kolonias D
- type
- Author
- name
- Rosenberg AE
- type
- Author
- name
- Kerr DA
- type
- Author
- name
- Sfakianaki E
- type
- Author
- name
- Foley M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Wilky BA
- type
- Author
- name
- Trucco MM
- type
- Author
- name
- Subhawong TK
- type
- Author
- name
- Florou V
- type
- Author
- name
- Park W
- type
- Author
- name
- Kwon D
- type
- Author
- name
- Wieder ED
- type
- Author
- name
- Kolonias D
- type
- Author
- name
- Rosenberg AE
- type
- Author
- name
- Kerr DA
- type
- Author
- name
- Sfakianaki E
- type
- Author
- name
- Foley M
- type
- Author
- bibliography ids
- nci-bib-fde18e07678c476ae459dbb6
- book metadata
- content sha256
- 2a6227926ab8f96e7da1c40c16e78e692317fa0445d687c69315f31b26a8a146
- document type
- citation
- dois
- 10.1016/S1470-2045(19)30153-6
- electronic publication date
- display
- 2019 May 8
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:31078463
- immutable id
- pubmed:31078463@2a6227926ab8f96e7da1c40c16e78e692317fa0445d687c69315f31b26a8a146
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 6
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 837-848
- volume
- 20
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2019 Jun;20(6):750-752. doi: 10.1016/S1470-2045(19)30286-4.
- note
- Source null
- related pmid
- 31078464
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 31078463
- provenance
- batch id
- e808962322f3afebc564
- provider
- NCBI PubMed ESummary
- record sha256
- ab93adb263ae38deb6e6e590963da3444e443101ecaa533f5c8e4236bc9716b7
- response sha256
- 3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
- retrieved at
- 2026-09-09T23:47:41.002093+00:00
- publication date
- display
- 2019 Jun
- precision
- month
- year
- 2019
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.
Preserved source evidence · Not medical advice
Triangle